UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000023335
Receipt No. R000026891
Official scientific title of the study Collection of side effects associated with the administration of bifidobacteria with the aim of fixing of the intestinal flora of pathological newborn.
Date of disclosure of the study information 2016/07/26
Last modified on 2017/12/04 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Collection of side effects associated with the administration of bifidobacteria with the aim of fixing of the intestinal flora of pathological newborn.
Title of the study (Brief title) Collection of side effects associated with the administration of bifidobacteria.
Region
Japan

Condition
Condition sick baby
Classification by specialty
Pediatrics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 data collecting
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes no side effect
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 administration of bifidobacteria
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
0 days-old <=
Age-upper limit
28 days-old >
Gender Male and Female
Key inclusion criteria sick baby
Key exclusion criteria intestinal bleeding
Target sample size 200

Research contact person
Name of lead principal investigator Keiji Goishi
Organization National Center for Global Health and Medicine
Division name Pediatrics
Address Toyama 1-21-1 Shinjuku
TEL 03-3202-7181
Email kgoishi@hosp.ncgm.go.jp

Public contact
Name of contact person Keiji Goishi
Organization National Center for Global Health and Medicine
Division name Pediatrics
Address Toyama 1-21-1 Shinjuku
TEL 03-3202-7181
Homepage URL
Email kgoishi@hosp.ncgm.go.jp

Sponsor
Institute National Center for Global Health and Medicine
Institute
Department

Funding Source
Organization National Center for Global Health and Medicine
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 07 Month 26 Day

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2015 Year 03 Month 16 Day
Anticipated trial start date
2015 Year 03 Month 16 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 07 Month 26 Day
Last modified on
2017 Year 12 Month 04 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026891